Sponsor
University Hospital Erlangen
Clinical research sponsor
Clinical trials
12 shownEvaluation of Compression Therapy in Patients With Mild to Moderate PAD or Diabetes MellitusNCT03384758 · lead sponsor · 2018-05-01
COMPLETEDHistScanning- Based PDR Brachytherapy in Prostate Cancer HistoScanning- Based Interstitial PDR BrachytherapyNCT01409876 · lead sponsor · 2011-09-01
UNKNOWNDose Optimization for Pulsed-dose-rate (PDR)/High-dose-rate (HDR) Brachytherapy Alone for Early Breast CancerNCT01175694 · lead sponsor · 2010-01-01
UNKNOWNSocial Prescriptions and Micro-Learning to Improve Care for Cancer Patients and Their Support PersonsNCT07788729 · collaborator · 2026-04-21
RECRUITINGWidening Aims and Giving Patients a Voice for Expanded Structures in Breast Cancer Care Jointly Developed by Patients and PhysiciansNCT06416293 · collaborator · 2022-04-01
RECRUITINGAssociation of Adjuvant Radiotherapy of Non-metastatic Breast Carcinoma With Immunomodulation and Circulating Tumor Cell Phenotype in Relation to Patient Age.NCT04902937 · collaborator · 2021-07-01
RECRUITINGNational Network Genomic Medicine Lung Cancer, GermanyNCT05934032 · collaborator · 2018-04-01
RECRUITINGMobilise-D: Extension StudyNCT05874739 · collaborator · 2023-05-17
UNKNOWNImmunosuppressive Treatment in Chronic Virus-Negative Inflammatory CardiomyopathyNCT05570409 · collaborator · 2023-03-28
TERMINATEDDigital GaitCare - Therapy Monitoring in the Home Environment of Patients With ParkinsonNCT04931303 · collaborator · 2021-06-24
COMPLETEDStudy to Compare a Mono Atezolizumab Window Followed by a Atezolizumab - CTX Therapy With Atezolizumab - CTX TherapyNCT04770272 · collaborator · 2021-03-01
TERMINATEDMobility in Atypical Parkinsonism: a Trial of PhysiotherapyNCT04608604 · collaborator · 2021-02-01
COMPLETEDSponsor roles
collaborator9
lead sponsor3
How to interpret this record
CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.